The Medicines Evaluation Unit is based in Manchester, United Kingdom and
specialises in performing clinical trials from Phase I through to IV, our core skill area being in Respiratory Medicine. Our facilities are located within the
Wythenshawe Hospital NHS site. This allows us the advantage of access to the hospital’s specialist support services, therefore we are ideally situated to
perform early phase exploratory studies.

The staff at the MEU are fully trained and experienced in the conduct of
single-site and multi-site studies, and have knowledge of a wide range of
therapeutic areas. With our purpose built 18 - bed in-patient facility, our high
level of technical expertise and fast recruitment rates we are able to offer
trial completion often well ahead of schedule.

The MEU has an outstanding reputation for performing high quality clinical
research complying with ICH GCP. The Unit has also undergone favourable
inspection by the MHRA (UK regulatory authority) and holds an MHRA Manufacturing
Assembly Licence.

Group Sector

Phase I-IV Capability

Clinical trials phase I – IV

Core skill area respiratory medicine

Based on the Wythenshawe Hospital site (an NHS teaching hospital based in
Manchester, UK) with full 24-hour emergency cover and access to ITU

Information on lung function tests (including reversibility), medical and
therapeutic history held for each patient to enable database searches to be
made on specific patient groups for individual studies

Over 500 COPD/Emphysema volunteers

Ongoing recruitment of rhinitis patients for inclusion in studies of
seasonal rhinitis

Over 1000 healthy volunteers (including ‘healthy’ ex and current smokers)
available for Phase 1 studies or comparator groups for later phase studies

Geographical Area

UK

Contact

David Rogers, Director of Operations
Liz Batty, Clinical Research Manager

CCRA is a not-for-profit organisation originally founded to represent independent clinical research contractors and allied industries.